BRANDL TRIXI has a total of 12 patent applications. Its first patent ever was published in 2007. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are KADMON CORP LLC, EISAI RANDD MAN CO LTD and CONDON STEPHEN M.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Peptides | |
#4 | Medical preparations | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Brandl Trixi | 12 |
#2 | Seepersaud Mohindra | 8 |
#3 | Rigollier Pascal | 8 |
#4 | Raman Prakash | 8 |
#5 | Simic Oliver | 8 |
#6 | Ehrhardt Claus | 3 |
#7 | Cottens Sylvain | 3 |
#8 | Fu Jiping | 3 |
#9 | Karur Subramanian | 3 |
#10 | Namoto Kenji | 2 |
Publication | Filing date | Title |
---|---|---|
US2012035168A1 | N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides | |
US2010260709A1 | Derivatised proline containing peptide compounds as protease inhibitors | |
US2011182850A1 | Organic compounds and their uses | |
US2008045530A1 | Organic Compounds and Their Uses | |
US2007238746A1 | Thiazolyl-dihydro-chinazoline |